empagliflozin 25mg+ metformin hydrochloride (extended release) 1000 mg

GLIEMPAFLOZIN MET ER is a combination medication used primarily to manage type 2 diabetes mellitus. This powerful formulation combines empagliflozin (25mg) and metformin hydrochloride (extended release) 1000mg, both of which play an essential role in regulating blood sugar levels in diabetic patients. Together, these active ingredients offer a holistic approach to diabetes management by targeting different mechanisms in the body.

Introduction to Metformin Hydrochloride (Extended Release)

The treatment of type 2 diabetes is multi-faceted, requiring the careful management of blood glucose levels. GLIEMPAFLOZIN MET ER brings together the therapeutic benefits of empagliflozin and metformin, making it a potent solution for controlling blood sugar. Empagliflozin, a SGLT2 inhibitor, works by blocking the reabsorption of glucose by the kidneys, promoting glucose excretion in the urine. Meanwhile, metformin, a widely used biguanide, reduces glucose production in the liver and increases insulin sensitivity in muscle cells.

By combining these two active ingredients in one tablet, GLIEMPAFLOZIN MET ER offers a convenient and effective treatment option for individuals struggling with type 2 diabetes.

Key Features and Ingredients

GLIEMPAFLOZIN MET ER contains the following key ingredients:

• Empagliflozin 25mg: A selective SGLT2 inhibitor that works by preventing the reabsorption of glucose from the kidneys, thus enhancing its excretion through urine. This action helps lower blood sugar levels and aids in weight loss, as excess glucose is expelled from the body.

• Metformin Hydrochloride (Extended Release) 1000mg: A biguanide that helps decrease hepatic glucose production, improve insulin sensitivity, and enhance glucose uptake by the cells, which ultimately helps in better glucose control.

Usage of Metformin Hydrochloride (Extended Release)

GLIEMPAFLOZIN MET ER is typically prescribed to patients with type 2 diabetes when diet and exercise alone are insufficient to control blood sugar levels. This medication is used in conjunction with a balanced diet and regular physical activity to help manage blood glucose effectively.

Dosage

• The usual dosage is 1 tablet once daily, preferably taken with food, to reduce the chances of gastrointestinal discomfort.

• The recommended starting dose is empagliflozin 25mg and metformin 1000mg (extended release).

• Adjustments may be made based on patient response and tolerance, as prescribed by the healthcare provider.

Precautions

• GLIEMPAFLOZIN MET ER should be used with caution in patients with kidney problems or those who have a history of lactic acidosis.

• It is important to follow your doctor’s advice regarding the appropriate dosage and potential side effects.

Benefits of Metformin Hydrochloride (Extended Release)

GLIEMPAFLOZIN MET ER offers multiple benefits, making it a preferred choice for type 2 diabetes management. Some of the key benefits include:

1. Enhanced Blood Sugar Control: The combination of empagliflozine and metformin works synergistically to provide more effective blood sugar control compared to monotherapy with either drug.

2. Weight Loss: One of the significant advantages of empagliflozin is its ability to induce weight loss due to the glucose being excreted through urine, which also promotes fat burning.

3. Cardiovascular Benefits: Studies suggest that empagliflozin offers heart benefits, particularly in diabetic patients who are at risk for heart disease. It can reduce the risk of cardiovascular death, making it a great choice for patients with existing heart issues.

4. Convenience: The extended-release formulation of metformin in GLIEMPAFLOZIN MET ER allows for once-daily dosing, improving patient adherence to treatment and minimizing the frequency of side effects like gastrointestinal disturbances.

5. Reduced Risk of Hypoglycemia: Since the medication works by improving insulin sensitivity rather than stimulating insulin production, GLIEMPAFLOZIN MET ER has a low risk of causing hypoglycemia (low blood sugar levels), making it a safer option for many patients.

6. Kidney Health: The SGLT2 inhibitor component, empagliflozin, has been shown to help protect kidney function over time, an important benefit for diabetic patients who are at increased risk of diabetic nephropathy.

Conclusion

In conclusion, GLIEMPAFLOZIN MET ER is a highly effective combination medication designed to manage type 2 diabetes. Its dual-action mechanism, involving empagliflozin and metformin, targets key aspects of blood glucose control, weight loss, and cardiovascular protection. By combining these two powerful ingredients, GLIEMPAFLOZIN MET ER offers a holistic and patient-friendly solution for those struggling to manage their diabetes effectively. Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma's product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW